Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

NYM vs PRE: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

PRE Wins Head-to-Head Institutional Verdict (4–1 across 6 Pillars · 6–2 Matrix Metrics)

PRE Overall Winner 6-Pillar Tally: NYM 1 – 4 PRE (1 Tie) Matrix Metrics: NYM 2 – 6 PRE

As of Nov 16, 2026, Prenetics Global Limited Class A Ordinary Share (PRE) is the stronger overall head-to-head candidate over NYM (NYM) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). NYM carries a Unified Composite Score of 46.2/100 (HOLD) at $24.53 (N/M Forward P/E, N/A operating margin), whereas PRE carries 49.8/100 (HOLD) at $15.48 (N/M Forward P/E, -34.6% operating margin).

  • Technical & Structure Timing Caution: NYM is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 50.0); meanwhile PRE is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 35.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About NYM vs PRE
NYM US Equity
NYM
Institutional Equity
$24.53
-0.18% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.05β · 4% Vol
Unified Composite Score
46.2 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -0.4%) with fading momentum, RSI 50
RSI-14: 50.0 · SMA20: $24.58 · SMA50: $24.37
PRE NASDAQ Head-to-Head Winner
Prenetics Global Limited Class A Ordinary Share
Laboratory Analytical Instruments
$15.48
-6.24% 1D
Market Cap $322.2M
TTM Revenue $155M
Forward P/E N/M
Beta / 30D Vol 1.63β · 74% Vol
Unified Composite Score
49.8 / 100 HOLD
Tech 33.0 Fund 59.0 Flow 76.0 Mom 67.8
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -9.0%), weak momentum, RSI 35
RSI-14: 35.1 · SMA20: $17.16 · SMA50: $20.26

6-Pillar Scorecard Institutional Category Breakdown (NYM 1 – 4 PRE)

Columns: Metric · NYM · PRE
1. Valuation Multiples PRE
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M 1.7x
2. Growth & Scale PRE
Revenue Growth (YoY) N/A +210.7%
Earnings Growth (YoY) N/A +0.0%
TTM Revenue (USD) N/A $155M
Market Cap N/A $322.2M
3. Profitability & Quality PRE
Gross Margin N/A 57.8%
Operating Margin N/A -34.6%
Net Profit Margin N/A -30.4%
Return on Equity (ROE) N/A -47.0%
4. Balance Sheet & Cash Flow PRE
Cash Generation (TTM) N/A -$54M EBITDA
Cash Flow Margin N/A -34.9% EBITDA Mgn
Net Cash / Leverage N/A ROE $58M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning NYM
Options Structure Phase UNCLASSIFIED BREAKDOWN
Current IV / %ile N/A (N/A) 124.1% (18th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Distribution NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Packaged Foods Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: NYM (2) vs PRE (6)
Institutional Metric NYM PRE Criterion Row Edge
Market Capitalization
Scale
N/A $322.2M Larger Scale PRE
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A +210.7% Higher Growth PRE
Operating Margin (TTM)
Profitability
N/A -34.6% Higher Margin PRE
Net Profit Margin
Profitability
N/A -30.4% Higher Margin PRE
Return on Equity (ROE)
Capital Efficiency
N/A -47.0% Higher ROE PRE
52-Week Range Position
Momentum
40% ($24–$25) 26% ($11–$27) Stronger Trend NYM
Beta / 30D Volatility
Risk Regime
0.05β · 4% Vol 1.63β · 74% Vol Lower Realized Risk NYM
Unified Institutional Score
Composite Signal
46.2 / 100 (HOLD) 49.8 / 100 (HOLD) Higher Composite PRE
Trailing 12M Revenue (USD)
Operating Scale
N/A $155M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 57.8% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · 1.7x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) -$54M EBITDA ($58M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon NYM +17.32 pp
NYM: +0.91% · PRE: -16.41%
3M Horizon NYM +18.98 pp
NYM: -1.23% · PRE: -20.21%
6M Horizon PRE +7.92 pp
NYM: -1.46% · PRE: +6.46%
1Y Horizon PRE +16.9 pp
NYM: -1.98% · PRE: +14.92%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NYM vs PRE. Trailing 12-month operating profitability (NYM N/A vs PRE -34.6%) and valuation multiples (NYM N/M vs PRE N/M Forward P/E) are benchmarked directly in Pillar 4 below.

NYM ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
PRE ADR TTM Benchmark FX-Normalized USD
TTM Revenue$155M
Gross Margin57.8%
Op. Margin-34.6%
ROE / Fwd P/E-47.0% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
NYM UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact NYM Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
PRE BREAKDOWN
56d in phase · OBV NEUTRAL
Current IV 124.1%
IV Percentile 18th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact PRE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
NYM Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
PRE Moat Profile Cyclical / Execution-Driven Positioning
Packaged Foods Operator
Competes within the Packaged Foods value chain with $322.2M market capitalization and -34.6% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ NYM vs PRE Key Questions & Quantitative Answers

As of Nov 16, 2026, Prenetics Global Limited Class A Ordinary Share (PRE) is the stronger overall head-to-head candidate over NYM (NYM) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). NYM carries a Unified Composite Score of 46.2/100 (HOLD) at $24.53 (N/M Forward P/E, N/A operating margin), whereas PRE carries 49.8/100 (HOLD) at $15.48 (N/M Forward P/E, -34.6% operating margin). Technical & Structure Timing Caution: NYM is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 50.0); meanwhile PRE is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 35.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

PRE leads the Growth & Scale pillar: NYM posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with PRE at +210.7% YoY revenue growth and +0.0% YoY earnings growth on $155M TTM revenue (57.8% gross margin, -34.6% operating margin). On trailing 12-month operating scale, NYM generates N/A in USD-normalized revenue versus $155M for PRE. In operating R&D and SG&A reinvestment, NYM deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for PRE.

PRE screens cheaper on headline valuation multiples. NYM trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas PRE trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 1.7x EV/Revenue (-34.9% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against NYM (N/A ROE) versus PRE (-47.0% ROE) capital efficiency.

In options market volatility and institutional positioning, NYM carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.05β · 4% Vol realized risk). By comparison, PRE carries 124.1% implied volatility (18th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (1.63β · 74% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.